Sphingosine‐1‐Phosphate Receptor 2 Agonist Mobilises Endogenous Muse Cells to Repair Damaged Myocardial Tissue in Male Rabbits
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Shingo Minatoguchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan. Hauptthemen laut MEDLINE: Myocardial Infarction, Receptors, Lysosphingolipid, Myocardium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and JSPS KAKENHI, Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
Muse cells, pluripotent stem cells present mainly in the bone marrow (BM) selectively accumulate to damaged tissue by sensing sphingosine‐1‐phosphate (S1P) and replace damaged cells by differentiating in situ. Acute myocardial infarction (AMI) model rabbits were subcutaneously injected either with Vehicle ( n = 15), S1PR2‐agonist ( n = 16), or S1PR2‐agonist + S1PR2‐antagonist ( n = 10). The number of Muse cells in the peripheral blood was assessed by flow cytometry at 12 h after AMI. The S1PR2‐agonist group showed a significant increase in the peripheral‐blood Muse cell number at 12 h ( p < 0.05), as well as infarct size reduction ( p < 0.05) and improvement of left ventricular (LV) function ( p < 0.05) at 2 weeks compared with the other 2 groups. The number of peripheral‐blood Muse cells positively correlated with LV ejection fraction ( p < 0.05) and inversely correlated with infarct size ( p < 0.05). Transplanted autologous green fluorescent protein (GFP)‐labelled BM‐Muse cells into the BM, followed by the administration of either Vehicle ( n = 5) or S1PR2 agonist ( n = 5) revealed a higher number of homed GFP‐Muse cells expressing the cardiac markers troponin‐I, α‐actinin, connexin‐43 and the vascular marker CD31 in the border areas in the S1PR2‐agonist group compared with the vehicle group. The mobilisation of endogenous Muse cells using S1PR2‐agonist may be a promising therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
- Heart Failure Center, Gifu Municipal Hospital, Gifu, Japan.
ORCID-Profile: Shinya Minatoguchi
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and JSPS KAKENHI
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Minatoguchi, S., Yamada, Y., Endo, N., Kanamori, H., Mikami, A., Okura, H., & Minatoguchi, S. (2025). Sphingosine‐1‐Phosphate Receptor 2 Agonist Mobilises Endogenous Muse Cells to Repair Damaged Myocardial Tissue in Male Rabbits. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70447
Vancouver
Minatoguchi S, Yamada Y, Endo N, Kanamori H, Mikami A, Okura H, et al. Sphingosine‐1‐Phosphate Receptor 2 Agonist Mobilises Endogenous Muse Cells to Repair Damaged Myocardial Tissue in Male Rabbits. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70447
BibTeX
@article{Minatoguchi2025,
author = {Minatoguchi, Shingo and Yamada, Yoshihisa and Endo, Noriko and Kanamori, Hiromitsu and Mikami, Atsushi and Okura, Hiroyuki and Minatoguchi, Shinya},
title = {Sphingosine‐1‐Phosphate Receptor 2 Agonist Mobilises Endogenous Muse Cells to Repair Damaged Myocardial Tissue in Male Rabbits},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70447}
}
EUVIMED